Stockreport

AbbVie Gets Even More Complicated With Allergan [Seeking Alpha]

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
PDF AbbVie Gets Even More Complicated With Allergan Summary AbbVie dropped to fresh 52-week lows following the $63B takeover bid for Allergan. AbbVie had already been facing [Read more]